Novavax Vaccine Prospects Take BioNTech, Moderna Shares Down By Investing.com
By Dhirendra Tripathi Investing.com – Shares of Covid-19 vaccine makers like BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) weakened on Monday on prospects of one more rival, Novavax (NASDAQ:NVAX), joining them in the market. BioNTech slumped 9% and Moderna by 8%. Pfizer (NYSE:PFE), which makes and markets the vaccine in collaboration with BioNTech, fell 1.5%. Johnson & Johnson (NYSE:JNJ), the only one with a single-dose vaccine, was down 0.5%. Novavax itself had a volatile session, giving up its gains of over 9% premarket to go...
Continue reading